Glucagon-Like Peptide-1 Receptor Ligand Interactions: Structural Cross Talk between Ligands and the Extracellular Domain

• Graham M. West,

  Affiliations Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America, Mass Spectrometry and Proteomics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America

  ⨯
• Francis S. Willard,

  Affiliation Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Kyle W. Sloop,

  Affiliation Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Aaron D. Showalter,

  Affiliation Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Bruce D. Pascal,

  Affiliations Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America, Informatics Core, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America

  ⨯
• Patrick R. Griffin

  * E-mail: pgriffin@scripps.edu

  Affiliation Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America

  ⨯